Work

A Myeloablative Regimen Incorporating Radiolabeled Anti-CD45 (BC8) Antibody Followed by Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Advanced Acute Myeloid Leukemia (AML).

Year: 2004

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v104.11.828.828

Authors: Eneida R. Nemecek, John M. Pagel, Joseph G. Rajendran, Darrell R. Fisher, Frederick R. Appelbaum, Oliver W. Press, Dana C. Matthews

Institutions: Fred Hutch Cancer Center, University of Washington

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2556567090

FWCI: 0.565

Cites:

Cited by: 2

Related to: 10